Research progress on the role of NMES1 gene in malignant tumors

doi:10.16352/j.issn.1001-6325.2024.03.0403

Abstract

Abstract: The normal esophageal mucosa specific 1 gene (NMES1) is considered as a tumor suppressor gene which significantly reduces expression of various malignant tumors. The NMES1 can affect various cellular biological behaviors such as proliferation, apoptosis and migration of tumor cells. These findings provide new strategies for searching early biomarkers or therapeutic targets of malignant tumors and support the evaluation of disease progression and prognosis.

Key words: NMES1, malignant tumor, cellular biological behavior

CLC Number:

WU Yuhong, YU Caiyuan, YE Shicai. Research progress on the role of NMES1 gene in malignant tumors[J]. Basic & Clinical Medicine, 2024, 44(3): 403-407.

References 25

[1]	Clayton SA, Daley KK, Macdonald L, et al. Inflammation causes remodeling of mitochondrial cytochrome c oxidase mediated by the bifunctional gene C15orf48[J]. Sci Adv, 2021, 7: eabl5182. doi:10.1126/sciadv.abl5182.
[2]	Endou M, Yoshida K, Hirota M, et al. Coxfa4l3, a novel mitochondrial electron transport chain complex 4 subunit protein, switches from Coxfa4 during spermatogenesis[J]. Mitochondrion, 2020, 52: 1-7. doi:10.1016/j.mito.2020.02.003.
[3]	Zhou J, Wang H, Lu A, et al. A novel gene, NMES1, downregulated in human esophageal squamous cell carcinoma[J]. Int J Cancer, 2002, 101: 311-316. doi:10.1002/ijc.10600.
[4]	Sorouri M, Chang T, Jesudhasan P, et al. Signatures of host-pathogen evolutionary conflict reveal MISTR-A conser-ved mitochondrial stress response network[J]. PLoS Biol, 2020, 18: e3001045. doi:10.1371/journal.pbio.3001045.
[5]	Musicco C, Signorile A, Pesce V, et al. Mitochondria deregulations in cancer offer several potential targets of therapeutic interventions[J]. Int J Mol Sci, 2023, 24. doi:10.3390/ijms241310420.
[6]	Morgan E, Soerjomataram I, Rumgay H, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020[J]. Gastroenterology, 2022, 163: 649-658.e642. doi:10.1053/j.gastro.2022.05.054.
[7]	Arai M, Imazeki F, Sakai Y, et al. Analysis of the methylation status of genes up-regulated by the demethylating agent, 5-aza-2′-deoxycytidine, in esophageal squamous cell carcinoma[J]. Oncol Rep, 2008, 20: 405-412.
[8]	Maher SG, Gillham CM, Duggan SP, et al. Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer[J]. Ann Surg, 2009, 250: 729-737. doi:10.1097/SLA.0b013e3181bce7e1.
[9]	Cao YN, Li QZ, Liu YX, et al. Discovering the key genes and important DNA methylation regions in breast cancer[J]. Hereditas, 2022, 159: 7. doi:10.1186/s41065-022-00220-5.
[10]	Kim DS, Lee WK, Park JY. Hypermethylation of normal mucosa of esophagus-specific 1 is associated with an unfavorable prognosis in patients with non-small cell lung cancer[J]. Oncol Lett, 2018, 16: 2409-2415. doi:10.3892/ol.2018.8915.
[11]	Zhao H, Wu L, Yan G, et al. Inflammation and tumor progression: signaling pathways and targeted intervention[J]. Signal Transduct Target Ther, 2021, 6: 263. doi:10.1038/s41392-021-00658-5.
[12]	Zhou Y, Wang S, Wu W, et al. Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecyc-line-induced mitochondrial respiratory deficiency in liver cancer[J]. EBioMedicine, 2023, 87: 104397. doi:10.1016/j.ebiom.2022.104397.
[13]	Feng J, Li J, Wu L, et al. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2020, 39: 126. doi:10.1186/s13046-020-01629-4.
[14]	Floyd BJ, Wilkerson EM, Veling MT, et al. Mitochon-drial protein interaction mapping identifies regulators of respiratory chain function[J]. Mol Cell, 2016, 63: 621-632. doi:10.1016/j.molcel.2016.06.033.
[15]	Wen S, Peng W, Chen Y, et al. Four differentially expressed genes can predict prognosis and microenvironment immune infiltration in lung cancer: a study based on data from the GEO[J]. BMC Cancer, 2022, 22: 193. doi:10.1186/s12885-022-09296-8.
[16]	穆雪峰,张燕,马于涛.人工智能在宫颈癌和宫颈癌前病变筛查和诊断中的应用[J].现代妇产科进展, 2023, 32: 65-68,72.
[17]	龙嘉,李黎明,许翠,等. HPV16E7靶向小干扰RNA对SiHa细胞增殖凋亡及6种抑癌基因的影响[J].中华皮肤科杂志, 2016, 49: 717-721.
[18]	Li L, Xu C, Long J, et al. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines[J]. Oncotarget, 2015, 6: 23930-23943. doi:10.18632/oncotarget.4525.
[19]	Li C, Tang Y, Li Q, et al. The prognostic and immune significance of C15orf48 in pan-cancer and its relationship with proliferation and apoptosis of thyroid carcinoma[J]. Front Immunol, 2023, 14: 1131870. doi:10.3389/fimmu.2023.1131870.
[20]	Kwan K, Castro-Sandoval O, Gaiddon C, et al. Inhibition of p53 protein aggregation as a cancer treatment strategy[J]. Curr Opin Chem Biol, 2023, 72: 102230. doi:10.1016/j.cbpa.2022.102230.
[21]	Tong X, Tang R, Xiao M, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research[J]. J Hematol Oncol, 2022, 15: 174. doi:10.1186/s13045-022-01392-3.
[22]	Spisak S, Kalmar A, Galamb O, et al. Genome-wide screening of genes regulated by DNA methylation in colon cancer development[J]. PLoS One, 2012, 7: e46215. doi:10.1371/journal.pone.0046215.
[23]	Lang ZQ, Wu YQ, Pan XB, et al. The identification of multifocal breast cancer-associated long non-coding RNAs[J]. Eur Rev Med Pharmacol Sci, 2017, 21: 5648-5654. doi:10.26355/eurrev_201712_14008.
[24]	Zheng SS, Wu YF, Zhang BH, et al. A novel myeloid cell marker genes related signature can indicate immune infiltration and predict prognosis of hepatocellular carcinoma: integrated analysis of bulk and single-cell RNA sequencing[J]. Front Mol Biosci, 2023, 10: 1118377. doi:10.3389/fmolb.2023.1118377.
[25]	Tian Y, Liu H, Zhang C, et al. Comprehensive analyses of ferroptosis-related alterations and their prognostic significance in glioblastoma[J]. Front Mol Biosci, 2022, 9: 904098. doi:10.3389/fmolb.2022.904098.